AlphaGrep UK’s Idexx Laboratories IDXX Stock Holding History

AlphaGrep UK’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-2,630	Closed	-$1.38M	–	861
2026 Q2	$1.38M	Buy	2,630 +1,680	+177%	+$942K	0.41%	12
2026 Q1	$534K	Buy	950 +475	+100%	+$305K	0.15%	217
2025 Q4	$321K	Buy	+475	New	+$323K	0.11%	386

Other funds holding IDXX

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $234B AUM 43.58% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

AlphaGrep UK's IDXX Position: Q3 2026 in Review

AlphaGrep UK sold out of Idexx Laboratories (IDXX) in Q3 2026, closing a stake of 2,630 shares — an estimated $1.38M sold.

AlphaGrep UK first reported a position in IDXX in Q4 2025 and held it in 3 quarters. The position peaked at $1.38M in Q2 2026. 1,073 funds tracked by Wall St. Rank hold IDXX as of Q3 2026.

AlphaGrep UK reported no remaining Idexx Laboratories position as of Q3 2026 after selling out during the quarter.
AlphaGrep UK sold 2,630 Idexx Laboratories shares in Q3 2026, an estimated $1.38M.
AlphaGrep UK first reported a position in Idexx Laboratories in Q4 2025 and held it in 3 quarters.
AlphaGrep UK's Idexx Laboratories position peaked at $1.38M in Q2 2026.
1,073 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2026.

Based on AlphaGrep UK's 13F filing for Q3 2026, filed 12 Nov 2026.